Free Trial

QRG Capital Management Inc. Invests $206,000 in Celsius Holdings Inc. (NASDAQ:CELH)

Celsius logo with Consumer Staples background

QRG Capital Management Inc. bought a new stake in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,775 shares of the company's stock, valued at approximately $206,000.

Other institutional investors have also recently made changes to their positions in the company. Triumph Capital Management increased its position in Celsius by 41.5% during the fourth quarter. Triumph Capital Management now owns 40,420 shares of the company's stock valued at $1,065,000 after acquiring an additional 11,863 shares during the last quarter. Fifth Third Bancorp boosted its stake in shares of Celsius by 62.9% during the 1st quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after purchasing an additional 666 shares during the period. Jones Financial Companies Lllp grew its holdings in Celsius by 21.9% during the 4th quarter. Jones Financial Companies Lllp now owns 17,350 shares of the company's stock valued at $457,000 after purchasing an additional 3,116 shares during the last quarter. GAMMA Investing LLC raised its position in Celsius by 4,164.4% in the 1st quarter. GAMMA Investing LLC now owns 73,092 shares of the company's stock worth $2,604,000 after purchasing an additional 71,378 shares during the period. Finally, Farther Finance Advisors LLC raised its position in Celsius by 32.4% in the 4th quarter. Farther Finance Advisors LLC now owns 2,509 shares of the company's stock worth $66,000 after purchasing an additional 614 shares during the period. Institutional investors own 60.95% of the company's stock.

Celsius Price Performance

Shares of CELH stock traded up $0.47 during mid-day trading on Friday, hitting $45.89. 6,441,424 shares of the stock traded hands, compared to its average volume of 8,134,162. Celsius Holdings Inc. has a 52-week low of $21.10 and a 52-week high of $61.25. The stock has a market cap of $11.83 billion, a P/E ratio of 143.41, a P/E/G ratio of 1.65 and a beta of 1.43. The stock's fifty day moving average is $38.98 and its two-hundred day moving average is $32.39.

Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). The firm had revenue of $329.28 million for the quarter, compared to analysts' expectations of $349.09 million. Celsius had a net margin of 8.40% and a return on equity of 42.12%. The company's revenue was down 7.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.27 EPS. As a group, equities analysts forecast that Celsius Holdings Inc. will post 0.89 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CELH. Stifel Nicolaus started coverage on shares of Celsius in a research note on Thursday, June 12th. They set a "buy" rating and a $47.00 target price for the company. Roth Capital reissued a "buy" rating and issued a $52.00 price objective (up from $46.00) on shares of Celsius in a research report on Thursday. Needham & Company LLC reaffirmed a "buy" rating and set a $47.00 target price on shares of Celsius in a research report on Thursday, May 29th. Wall Street Zen upgraded Celsius from a "sell" rating to a "hold" rating in a report on Friday. Finally, Truist Financial increased their price objective on Celsius from $45.00 to $50.00 and gave the stock a "buy" rating in a research note on Friday, June 6th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $45.18.

Read Our Latest Stock Analysis on CELH

Insider Activity

In other Celsius news, CEO John Fieldly sold 130,803 shares of Celsius stock in a transaction dated Tuesday, June 24th. The stock was sold at an average price of $45.00, for a total transaction of $5,886,135.00. Following the completion of the transaction, the chief executive officer now owns 1,038,577 shares in the company, valued at approximately $46,735,965. This trade represents a 11.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 2.55% of the company's stock.

Celsius Profile

(Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Featured Stories

Institutional Ownership by Quarter for Celsius (NASDAQ:CELH)

Should You Invest $1,000 in Celsius Right Now?

Before you consider Celsius, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.

While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines